Page 7 - CPG endometrial cancer

2

แนวทางการตรวจคดั กรอง วินิจฉยั และรกั ษาโรคมะเรง็ เย่อื บโุ พรงมดลกู

เอกสารอา้ งอิง

1. National cancer institute. Cancer Anywhere. J Dept Med Ser [Internet]. 2022 Dec. 28;47(4):5-9.
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN

estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021: 71: 209-249.
3. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15(1):10-7.
4. Emons G, Mustea A, Tempfer C. Tamoxifen and Endometrial Cancer: A Janus-Headed Drug. Cancers (Basel) 2020; 12(9):2535.
5. Cancer Genome Atlas Research Network; Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated

genomic characterization of endometrial carcinoma. Nature 2013;497(7447):67-73.
6. Talhouk A, McAlpine JN. New classification of endometrial cancers: the development and potential applications of

genomic-based classification in research and clinical care. Gynecol Oncol Res Pract 2016;3:14.
7. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al; Endometrial cancer staging subcommittee,

FIGO women's cancer committee. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet 2023;162:383-94.
8. National Comprehensive Cancer Network ( NCCN) [ internet] . NCCN Clinical Practice Guidelines in Oncology. Uterine

Neoplasm Version 2.2023. [cited 2023 Apr 28]. Available from: https://www.nccn.org/ professionals/ physician_gls/
pdf/uterine.pdf. Accessed on September 23, 2023.
9. Oaknin A, Bosse TJ, Creutzberg CL, Giornelli G, Harter P, Joly F, et al. Endometrial cancer: ESMO clinical practice guideline
for diagnosis, treatment and follow-up. Ann Oncol 2022;33(9):860-877.
10. Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO/ESTRO/ESP guidelines for the management
of patients with endometrial carcinoma. Int J Gynecol Cancer 2021;31(1):12-39.